Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (9)
  • 2025 (26)
  • 2024 (19)
  • 2023 (14)
  • 2022 (24)
  • 2021 (49)
  • 2020 (41)
  • 2019 (40)
  • 2018 (48)
  • 2017 (44)
  • 2016 (41)
  • 2015 (34)
  • 2014 (28)
  • 2013 (64)
  • 2012 (14)
  • 2011 (58)

Subject

  • Drug Trafficking (34)
  • Take Back Day (34)
  • Outreach/Drug Prevention (26)
  • Prescription Drugs (24)
  • Public and Media Affairs - also see Congressional Affairs (18)
  • Synthetic drugs (15)
  • Fake Pills (14)
  • Congressional Affairs (12)
  • Arrests/Convictions - Major (11)
  • Major Law Enforcement Operation (11)
  • Press Conferences (11)
  • Diversion Division (10)
  • Fentanyl Awareness (10)
  • Pharmaceuticals/Pharmacists/Physicians (10)
  • Prevention/Education - DEA websites GSAD, JTT etc (10)
  • Red Ribbon (9)
  • Guns/Weapons (8)
  • One Pill Can Kill (8)
  • Money Laundering (7)
  • Overdose (7)
  • OCDETF/Task Force (5)
  • Seizures (Drugs/Property) (5)
  • Extraditions (4)
  • Fentanyl Free America (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Narcoterrorism (4)
  • Counterfeit Pills (3)
  • Critical Incident (3)
  • Gangs (3)
  • Campaigns (2)
  • Intelligence Division - Intelligence Products (2)
  • Scam Calls (2)
  • Task Forces/Task Force Officers (2)
  • Terrorism (2)
  • Dark Web- Internet Trafficking (1)
  • HIDTA (1)
  • Museum and Visitors Center (1)
  • Other (1)

Drug Name

  • Fentanyl (46)
  • Cocaine (24)
  • Methamphetamine (20)
  • Heroin (12)
  • Marijuana (Cannabis) (7)
  • Opioids (5)
  • Oxycodone (5)
  • Synthetic Opioids (5)
  • Marijuana Concentrates (2)
  • Ecstasy/MDMA (1)
  • GHB (1)
  • Ketamine (1)
  • Psilocybin (1)

Field Division

  • New England (2403)
  • New York (1524)
  • Houston (915)
  • Miami (857)
  • San Francisco (849)
  • Seattle (823)
  • St. Louis (809)
  • Atlanta (786)
  • Chicago (635)
  • Washington, DC (618)
  • New Jersey (494)
  • New Orleans (490)
  • Detroit (362)
  • El Paso (354)
  • Dallas (318)
  • Los Angeles (303)
  • Phoenix (276)
  • San Diego (247)
  • Rocky Mountain (167)
  • Omaha (140)
  • Louisville (84)
  • Caribe (79)
  • Caribe (1)
  • Sede (418)
  • Philadelphia (140)
Clear All Results
553 Results - Showing 341 to 350
PRESS RELEASE

Over 20 People Indicted In Coraopolis Drug Operation

CORAOPOLIS, Pa. - The Special Agent in (SAC) of the Drug Enforcement Administration’s Philadelphia Division, Gary Tuggle and the Chief of the Coraopolis Police Department, Ronald Denbow announced the indictment of 22 people for violations of the Pennsylvania Controlled Substance Drug, Device and Cosmetic Act. The indictment of 17 men...
PRESS RELEASE

DEA’s National Prescription Drug Take-Back Day Is Saturday

WASHINGTON - After collecting and destroying 5.5 million pounds-2,762 tons-of unused prescription drugs in the past five years, the U.S. Drug Enforcement (DEA) is continuing its efforts to take back unused, unwanted and expired prescription medications. The DEA invites the public to bring their potentially dangerous, unwanted medicines to one...
PRESS RELEASE

DEA Announces 11th National Prescription Drug Take-Back Day

PHILADELPHIA - Special Agent in Charge Gary Tuggle announced today that the Drug Enforcement Administration’(DEA) Philadelphia Field Division will conduct its 11th National Prescription Drug Take-Back Day event across Pennsylvania and Delaware on April 30 between 10:00 a.m. and 2:00 p.m. As with previous Take-Back events, approximately 300 collection sites...
PRESS RELEASE

DEA To Sponsor Off-Script Play For Valley High School As Part Of The 360 Strategy To Address Prescription Opioid And Heroin Abuse

PHILADELPHIA - Special Agent in Charge Gary Tuggle of the Drug Enforcement Administration’(DEA) Philadelphia Division announced today that the DEA will sponsor a play entitled Off-Script for the junior and senior high school students of Valley High School as part of the DEA’s ongoing 360 Strategy to address prescription opioid...
PRESS RELEASE

DEA & FBI Host Screening Of Chasing The Dragon For Local Educators To Combat Prescription Opioid And Heroin Epidemic

PHILADELPHIA - DEA Assistant Special Agent in Charge David Cali and Federal Bureau of Investigation Special Agent in Charge William F. Sweeney hosted a screening of Chasing the Dragon: The Life on an Opiate Addict for local educators and media representatives at the William J. Green Federal Building in Philadelphia...
PRESS RELEASE

DEA To Train Philadelphia Area Law Enforcement On Heroin Overdose Investigations To Combat Epidemic Of Prescription Opioid And Heroin Abuse

PHILADELPHIA - Special Agent in Charge Gary Tuggle of the Drug Enforcement (DEA) announced today the Philadelphia area release of “Operation Trojan Horse,” which is a coordinated effort between the DEA and state and local law enforcement agencies to combat the current prescription opioid and heroin abuse epidemic. The DEA...
PRESS RELEASE

DEA To Sponsor Off-Script Play For High School Students As Part Of The 360 Strategy To Address Prescription Opioid And Heroin Abuse

PHILADELPHIA - Special Agent in Charge Gary Tuggle of the Drug Enforcement Administration’(DEA) Philadelphia Field Division announced today that the DEA will sponsor a play entitled Off-Script for the students of Mount Pleasant High School as part of the DEA’s ongoing 360 Strategy to address prescription opioid and heroin abuse...
PRESS RELEASE

Members Of Chester Drug Trafficking Organization Convicted

PHILADELPHIA - Special Agent in Charge Gary Tuggle of the Drug Enforcement Administration’(DEA) Philadelphia Field Division announced today that a federal jury returned guilty verdicts against members of a violent drug trafficking organization that operated in and around Chester, Pennsylvania. The jury found Donald Womack, Sr., Paris Church, Ronell Whitehead...
PRESS RELEASE

DEA To Conduct Pharmacy Diversion Awareness Conference In Wilmington To Address The Diversion Of Prescription Opioids And Link To Heroin Abuse

PHILADELPHIA - Special Agent in Charge Gary Tuggle of the Drug Enforcement Administration’(DEA) Philadelphia Field Division announced today that the DEA will host a Pharmacy Diversion Awareness (PDAC) in Wilmington, Delaware as part of the DEA’s mission to address prescription opioid and heroin abuse. The diversion of pharmaceutical controlled substances...
PRESS RELEASE

DEA Meets With Pharmaceutical Industry Leaders Today To Discuss Collaboratively Preventing Prescription Drug Misuse And Abuse

WASHINGTON - U.S. Drug Enforcement (DEA) Acting Administrator Chuck Rosenberg and the Chief of DEA’s Office of Diversion Control, Lou Milione hosted a meeting today in Washington with industry leaders representing the prescription drug supply chain in America. The purpose of their dialogue was to discuss ways to minimize pharmaceutical...

Paginación

  • Primera página «
  • Anterior
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Current page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster